苯环己哌啶:修订间差异
删除的内容 添加的内容
←建立内容为“'''苯环己哌啶'''(Phencyclidine),俗称'''天使尘''',是一种解离性麻醉剂,主要用于娱乐用途,具有显著的改变精神状态的作用。其可能引发幻觉及听觉感知扭曲。作为一种娱乐药物,常被吸食,或是口服与注射使用,也可与大麻与烟草混合。”的新页面 |
无编辑摘要 |
||
第1行: | 第1行: | ||
{{Infobox drug |
|||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
|||
| verifiedrevid = 464373911 |
|||
| drug_name = |
|||
| IUPAC_name = 1-(1-Phenylcyclohexyl)piperidine |
|||
| image = Phencyclidine.svg |
|||
| width = 135px |
|||
| image2 = Phencyclidine-from-xtal-3D-balls.png |
|||
| width2 = 225px |
|||
<!--Clinical data--> |
|||
| tradename = Sernyl, Sernylan (both discontinued) |
|||
| Drugs.com = {{drugs.com|parent|phencyclidine}} |
|||
| MedlinePlus = |
|||
| licence_EU = |
|||
| licence_US = |
|||
| pregnancy_AU = |
|||
| pregnancy_US = |
|||
| pregnancy_category = |
|||
| legal_AU = S9 |
|||
| legal_BR = A3 |
|||
| legal_CA = Schedule I |
|||
| legal_DE = Anlage I |
|||
| legal_NZ = Class A |
|||
| legal_UK = Class A |
|||
| legal_US = Schedule II |
|||
| legal_UN = P II |
|||
<!--not a param | legal_IT = Tabella I --> |
|||
| routes_of_administration = [[Smoking]], [[Injection (medicine)|injection]], [[Insufflation (medicine)|snorted]], [[oral administration|by mouth]]<ref name="Giannini 1998">{{cite book | vauthors = Giannini AJ |year=1998 |chapter=Chapter 35: Phencyclidine |chapter-url=https://books.google.com/books?id=-0r0BwAAQBAJ&pg=PA579 | veditors = Tarter RE, Ammerman R, Ott PJ |title=Handbook of Substance Abuse: Neurobehavioral Pharmacology |location=[[New York City|New York]] |publisher=[[Plenum Publishing Corporation]] |pages=579–587 |isbn=978-1-4757-2913-9}}</ref><ref name=NIH2018Fact/> |
|||
| legal_status = |
|||
| addiction_liability = Variable, reported from low to high<ref name="NHM-PCP and ketamine"/><ref>{{cite book| vauthors = Stobo JD, Traill TA, Hellmann DB, Ladenson PW, Petty BG |title=The Principles and Practice of Medicine|date=1996|publisher=McGraw Hill Professional|isbn=9780071383653|page=933|url=https://books.google.com/books?id=aA9mMB3lDh4C|language=en|quote= high abuse liability}}</ref><ref>{{cite book| vauthors = Fetting M |title=Perspectives on Substance Use, Disorders, and Addiction: With Clinical Cases|date=2015|publisher=SAGE Publications|isbn=9781483377773|page=145|url=https://books.google.com/books?id=7qxiCgAAQBAJ&pg=PT145|language=en}}</ref> |
|||
| class = [[NMDA receptor antagonists]]; [[General anesthetics]]; [[Dissociative hallucinogen]]s<ref name="Giannini 1998"/> |
|||
<!--Pharmacokinetic data--> |
|||
| bioavailability = |
|||
| protein_bound = |
|||
| metabolism = [[Oxidation|Oxidative]] [[hydroxylation]] in [[liver]] by [[cytochrome P450|CYP450]] [[enzyme]]s, [[glucuronidation]] |
|||
| metabolites = PCHP, PPC, PCAA |
|||
| onset = 2–60 min<ref name=Ri2010>{{cite book| vauthors = Riviello RJ |title=Manual of forensic emergency medicine : a guide for clinicians|date=2010|publisher=Jones and Bartlett Publishers|location=Sudbury, Mass.|isbn=9780763744625|pages=41–42|url=https://books.google.com/books?id=keng9ELAE2IC&pg=PA41}}</ref> |
|||
| elimination_half-life = 7–46 hours |
|||
| duration_of_action = 6–48 hours<ref name=Ri2010/> |
|||
| excretion = [[Urine]] |
|||
<!--Identifiers--> |
|||
| IUPHAR_ligand = 4282 |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 77-10-1 |
|||
| ATC_prefix = None |
|||
| PubChem = 6468 |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| DrugBank = DB03575 |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 6224 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = J1DOI7UV76 |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
| KEGG = C07575 |
|||
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|||
| ChEBI = 8058 |
|||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|||
| ChEMBL = 275528 |
|||
| synonyms = CI-395; Phenylcyclohexylpiperidine; "Angel dust"<ref name=Jus2003/> |
|||
<!--Chemical data--> |
|||
| C=17 | H=25 | N=1 |
|||
| SMILES = |
|||
c1ccccc1C2(CCCCC2)N3CCCCC3 |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = 1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2 |
|||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = JTJMJGYZQZDUJJ-UHFFFAOYSA-N |
|||
<!--Physical data--> |
|||
| melting_point = 46.5 |
|||
| melting_high = |
|||
| boiling_point = 136 |
|||
}} |
|||
'''苯环己哌啶'''(Phencyclidine),俗称'''天使尘''',是一种[[解离剂|解离性麻醉剂]],主要用于娱乐用途,具有显著的改变精神状态的作用。其可能引发幻觉及听觉感知扭曲。作为一种娱乐药物,常被吸食,或是口服与注射使用,也可与大麻与烟草混合。 |
'''苯环己哌啶'''(Phencyclidine),俗称'''天使尘''',是一种[[解离剂|解离性麻醉剂]],主要用于娱乐用途,具有显著的改变精神状态的作用。其可能引发幻觉及听觉感知扭曲。作为一种娱乐药物,常被吸食,或是口服与注射使用,也可与大麻与烟草混合。 |
2023年10月1日 (日) 17:44的版本
臨床資料 | |
---|---|
商品名 | Sernyl, Sernylan (both discontinued) |
其他名稱 | CI-395; Phenylcyclohexylpiperidine; "Angel dust"[1] |
AHFS/Drugs.com | phencyclidine |
成癮性 | Variable, reported from low to high[2][3][4] |
给药途径 | Smoking, injection, snorted, by mouth[5][6] |
藥物類別 | NMDA receptor antagonists; General anesthetics; Dissociative hallucinogens[5] |
ATC碼 |
|
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
药物代谢 | Oxidative hydroxylation in liver by CYP450 enzymes, glucuronidation |
代謝產物 | PCHP, PPC, PCAA |
藥效起始時間 | 2–60 min[7] |
生物半衰期 | 7–46 hours |
作用時間 | 6–48 hours[7] |
排泄途徑 | Urine |
识别信息 | |
| |
CAS号 | 77-10-1 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.150.427 |
化学信息 | |
化学式 | C17H25N |
摩尔质量 | 243.39 g·mol−1 |
3D模型(JSmol) | |
熔点 | 46.5 °C(115.7 °F) |
沸点 | 136 °C(277 °F) |
| |
|
苯环己哌啶(Phencyclidine),俗称天使尘,是一种解离性麻醉剂,主要用于娱乐用途,具有显著的改变精神状态的作用。其可能引发幻觉及听觉感知扭曲。作为一种娱乐药物,常被吸食,或是口服与注射使用,也可与大麻与烟草混合。
- ^ 引用错误:没有为名为
Jus2003
的参考文献提供内容 - ^ 引用错误:没有为名为
NHM-PCP and ketamine
的参考文献提供内容 - ^ Stobo JD, Traill TA, Hellmann DB, Ladenson PW, Petty BG. The Principles and Practice of Medicine. McGraw Hill Professional. 1996: 933. ISBN 9780071383653 (英语).
high abuse liability
- ^ Fetting M. Perspectives on Substance Use, Disorders, and Addiction: With Clinical Cases. SAGE Publications. 2015: 145. ISBN 9781483377773 (英语).
- ^ 5.0 5.1 Giannini AJ. Chapter 35: Phencyclidine. Tarter RE, Ammerman R, Ott PJ (编). Handbook of Substance Abuse: Neurobehavioral Pharmacology. New York: Plenum Publishing Corporation. 1998: 579–587. ISBN 978-1-4757-2913-9.
- ^ 引用错误:没有为名为
NIH2018Fact
的参考文献提供内容 - ^ 7.0 7.1 Riviello RJ. Manual of forensic emergency medicine : a guide for clinicians. Sudbury, Mass.: Jones and Bartlett Publishers. 2010: 41–42. ISBN 9780763744625.